1. Germany Stocks

  2. •

    Healthcare

  3. •

    Medical - Care Facilities
RHON-KLINIKUM AG Unsponsored ADR

RHON-KLINIKUM AG Unsponsored ADR

RKAGY
RHON-KLINIKUM AG Unsponsored ADRUS flagOther OTC
8.16
USD
- -
- -
1.09BMarket Cap

Total Valuation

RHON-KLINIKUM AG Unsponsored ADR carries a market capitalization of 1.09B, placing it among publicly traded companies globally. Its enterprise value stands at 280.78M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.09B
Enterprise Value280.78M

Share Statistics

RHON-KLINIKUM AG Unsponsored ADR currently has 66.94M shares outstanding.

Shares Outstanding66.94M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

RHON-KLINIKUM AG Unsponsored ADR trades at a trailing price-to-earnings ratio of 22.24. The price-to-sales ratio is 0.50, and the price-to-book ratio stands at 5.06.

PE Ratio22.24
PS Ratio0.50
PB Ratio5.06
P/TBV Ratio0.73
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, RHON-KLINIKUM AG Unsponsored ADR trades at an EV/EBITDA multiple of 7.56 and an EV/FCF ratio of 104.53. The EV/Sales ratio of 0.17 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 7.56 provides insight into valuation relative to core operating earnings.

EV / Sales0.17
EV / EBITDA7.56
EV / EBIT7.56
EV / FCF104.53

Financial Position

RHON-KLINIKUM AG Unsponsored ADR maintains a current ratio of 2.34, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities.

Current Ratio2.34
Quick Ratio1.49
Debt / EquityN/A
Debt / EBITDAN/A
Interest Coverage10.89

Financial Efficiency

RHON-KLINIKUM AG Unsponsored ADR posts a return on equity of 22.76 and a return on invested capital of 2.19.

Return on Equity (ROE)22.76
Return on Assets (ROA)2.06
Return on Invested Capital (ROIC)2.19
Return on Capital Employed (ROCE)19.77
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover58.48

Taxes

Over the trailing twelve months, RHON-KLINIKUM AG Unsponsored ADR has paid 10.76M in income taxes, reflecting an effective tax rate of 21.23.

Income Tax10.76M
Effective Tax Rate21.23

Stock Price Statistics

RHON-KLINIKUM AG Unsponsored ADR's stock has gained approximately 6.66667% over the past 52 weeks. The 50-day moving average sits at 8.16, while the 200-day moving average is 7.74.

Beta (5Y)N/A
52-Week Price Change6.66667%
50-Day Moving Average8.16
200-Day Moving Average7.74
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, RHON-KLINIKUM AG Unsponsored ADR generated 1.69B in revenue and converted that into 38.11M in net income, yielding earnings per share of 0.30. EBITDA reached 37.13M, while operating income came in at 37.13M.

Revenue1.69B
Gross Profit-321.30M
Operating Income37.13M
Pretax Income50.69M
Net Income38.11M
EBITDA37.13M
EBIT37.13M
Earnings Per Share (EPS)0.30

Balance Sheet

Total book value stands at 167.41M, with working capital of 535.88M providing operational flexibility.

Cash & Cash Equivalents596.99M
Total DebtN/A
Net Debt-231.03M
Equity (Book Value)167.41M
Book Value Per Share1.24
Working Capital535.88M

Margins

RHON-KLINIKUM AG Unsponsored ADR operates with a gross margin of -19.05, reflecting its pricing power and cost economics. The operating margin of 2.20 and net profit margin of 2.26 provide insight into operational efficiency.

Gross Margin-19.05
Operating Margin2.20
Pretax Margin3.01
Profit Margin2.26
EBITDA Margin2.20

Scores

RHON-KLINIKUM AG Unsponsored ADR posts an Altman Z-Score of 2.42, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score2.42